What is the address of Farmavix?

The registered office of Farmavix is located at Kortrijkstraat(LIN) 144, 3210 Lubbeek.

Is Farmavix still active?

Yes. According to the CBE (16 September 2026) Farmavix is active, legal situation “Normale toestand”, started on 19 November 2013.

Is Farmavix registered on Peppol?

Yes, Farmavix is registered on the Peppol network with ID 0208:0541979283.

What is the enterprise number of Farmavix?

The enterprise number of Farmavix is BE0541979283.

When was Farmavix founded?

Farmavix was founded on 19 November 2013.

Who are the directors of Farmavix?

According to the 2025 annual accounts, the directors of Farmavix are: Viky Gilis.

Is Farmavix a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 November 2013; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did Farmavix make in 2025?

Farmavix posted a profit after taxes of € 9,189 in financial year 2025.

What is the revenue of Farmavix?

As a small company, Farmavix is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 33,858.

Farmavix (Private Limited) - Lubbeek - BE0541979283

Q: What does Farmavix do?

Farmavix is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 19 November 2013, 2 establishments.

Dossier Farmavix, printed on 16 September 2026 from databakkes.be/en/0541979283/farmavix. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Farmavix from Lubbeek, company number BE0541979283, closed financial year 2025 with a result of € 9,189 after tax. For that financial year Farmavix recorded a gross margin of € 33,858 and equity of € 142,015. Compared with financial year 2024, the result moved from € 22,954 to € 9,189. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 10, 2026.

What it is worth Growing

€ 142,015

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 9,189

▼ 60% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 135,528

▼ 32% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 135,815.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 43,831

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 31,812

▼ 25% vs 2024

€ 11,105 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 2,166

▼ 74% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,329

▼ 81% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 49,585 Gross margin 2022: € 49,585 First fiscal year in the series	€ 40,802 Gross margin 2023: € 40,802 ▼ 18% vs 2022 (€ 49,585) Unfavourable step	€ 56,608 Gross margin 2024: € 56,608 ▲ 39% vs 2023 (€ 40,802) Favourable step	€ 33,858 Gross margin 2025: € 33,858 ▼ 40% vs 2024 (€ 56,608) Unfavourable step	▼ 40%
Profit after taxes	€ 27,477 Profit after taxes 2022: € 27,477 First fiscal year in the series	€ 19,408 Profit after taxes 2023: € 19,408 ▼ 29% vs 2022 (€ 27,477) Unfavourable step	€ 22,954 Profit after taxes 2024: € 22,954 ▲ 18% vs 2023 (€ 19,408) Favourable step	€ 9,189 Profit after taxes 2025: € 9,189 ▼ 60% vs 2024 (€ 22,954) Unfavourable step	▼ 60%
Equity	€ 90,463 Equity 2022: € 90,463 First fiscal year in the series	€ 109,872 Equity 2023: € 109,872 ▲ 21% vs 2022 (€ 90,463) Favourable step	€ 132,826 Equity 2024: € 132,826 ▲ 21% vs 2023 (€ 109,872) Favourable step	€ 142,015 Equity 2025: € 142,015 ▲ 7% vs 2024 (€ 132,826) Favourable step	▲ 7%
Total debts	€ 106,374 Total debts 2022: € 106,374 First fiscal year in the series	€ 141,812 Total debts 2023: € 141,812 ▲ 33% vs 2022 (€ 106,374) Unfavourable step	€ 132,387 Total debts 2024: € 132,387 ▼ 7% vs 2023 (€ 141,812) Favourable step	€ 52,714 Total debts 2025: € 52,714 ▼ 60% vs 2024 (€ 132,387) Favourable step	▼ 60%
Cash	€ 182,285 Cash 2022: € 182,285 First fiscal year in the series	€ 167,689 Cash 2023: € 167,689 ▼ 8% vs 2022 (€ 182,285) Unfavourable step	€ 200,180 Cash 2024: € 200,180 ▲ 19% vs 2023 (€ 167,689) Favourable step	€ 135,528 Cash 2025: € 135,528 ▼ 32% vs 2024 (€ 200,180) Unfavourable step	▼ 32%
Retained profit	€ 84,263 Retained profit 2022: € 84,263 First fiscal year in the series	€ 103,672 Retained profit 2023: € 103,672 ▲ 23% vs 2022 (€ 84,263) Favourable step	€ 126,626 Retained profit 2024: € 126,626 ▲ 22% vs 2023 (€ 103,672) Favourable step	€ 135,815 Retained profit 2025: € 135,815 ▲ 7% vs 2024 (€ 126,626) Favourable step	▲ 7%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 52,538 Bank debt 2023: € 52,538 Unchanged (€ 0) Unfavourable step	€ 42,417 Bank debt 2024: € 42,417 ▼ 19% vs 2023 (€ 52,538) Favourable step	€ 31,812 Bank debt 2025: € 31,812 ▼ 25% vs 2024 (€ 42,417) Favourable step	▼ 25%
Balance sheet total	€ 196,838 Balance sheet total 2022: € 196,838 First fiscal year in the series	€ 251,683 Balance sheet total 2023: € 251,683 ▲ 28% vs 2022 (€ 196,838) Unchanged	€ 265,213 Balance sheet total 2024: € 265,213 ▲ 5% vs 2023 (€ 251,683) Unchanged	€ 194,729 Balance sheet total 2025: € 194,729 ▼ 27% vs 2024 (€ 265,213) Unchanged	▼ 27%

Key figures of Farmavix, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Farmavix?

What happened at Farmavix in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 10, 2026 New annual accounts for financial year 2025: profit of € 9,189 (▼ 60% vs 2024). filed late Source: NBB ↗
Feb 4, 2014 New establishment in Beauvechain. KBO
Nov 19, 2013 New establishment in Lubbeek. KBO
Nov 19, 2013 Start of the company according to the CBE. KBO

In short

From € 27,477 profit in 2022 to € 9,189 profit in 2025.

Paid € 47,275 in corporate taxes since 2022.

Best year ever: 2022, with € 27,477 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Farmavix? We notify you, reason included.

Follow Farmavix

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Viky Gilis

Farmavix

Behind Farmavix is Viky Gilis.

See the full network in the app

Directors

According to the 2025 annual accounts

Viky Gilis

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Kortrijkstraat(LIN) 144

3210 Lubbeek

2.226.259.272

Rue du Petit Paradis,H.-M. 7

1320 Beauvechain

Active since 4 February 2014

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Gilis&Schoofs1

Gilis&Schoofs2

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0541.979.283

VAT number

BE 0541.979.283

Registered office

Kortrijkstraat(LIN) 144, 3210 Lubbeek

Names & denominations

Farmavix

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

19 November 2013

Peppol

Active · Active since 18 Sept 2025

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

Farmavix

Financials

What happened to Farmavix?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions